{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:19:42Z","timestamp":1772547582488,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.yebeh.2023.109601","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T10:23:25Z","timestamp":1704709405000},"page":"109601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing"],"prefix":"10.1016","volume":"151","author":[{"given":"Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-chan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-li","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-207X","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109601_b0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-444-64148-9.00011-9","article-title":"Epilepsy","volume":"174","author":"Bastos","year":"2020","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2023.109601_b0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1055\/s-0040-1718719","article-title":"Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology","volume":"40","author":"Falco-Walter","year":"2020","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2023.109601_b0015","doi-asserted-by":"crossref","first-page":"106662","DOI":"10.1016\/j.yebeh.2019.106662","article-title":"Prevalence of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy from western China: A cross-sectional survey","volume":"104","author":"Yang","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109601_b0020","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1212\/WNL.0000000000201604","article-title":"Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing","volume":"100","author":"Li","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109601_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119342","article-title":"Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications","volume":"275","author":"Carona","year":"2021","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109601_b0030","first-page":"508","article-title":"Update on Antiepileptic Drugs 2019","volume":"25","author":"Abou-Khalil","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109601_b0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/17425255.2017.1360278","article-title":"Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures","volume":"13","author":"de Biase","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2023.109601_b0040","unstructured":"Dean, L., Lacosamide Therapy and CYP2C19 Genotype. 2018."},{"issue":"3","key":"10.1016\/j.yebeh.2023.109601_b0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/FTD.0000000000000927","article-title":"Impact of ABCB1 Polymorphisms on Lacosamide Serum Concentrations in Uygur Pediatric Patients With Epilepsy in China","volume":"44","author":"Zhao","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109601_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FTD.0000000000001003","article-title":"Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China","volume":"45","author":"Zhao","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109601_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13318-022-00808-2","article-title":"Therapeutic Drug Monitoring of Lacosamide in Chinese Pediatric Patients with Epilepsy: Efficacy and Factors Influencing the Plasma Concentration","volume":"48","author":"Zhao","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"11","key":"10.1016\/j.yebeh.2023.109601_b0060","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/epi.17399","article-title":"Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy","volume":"63","author":"Ahn","year":"2022","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109601_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13318-019-00598-0","article-title":"How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective","volume":"45","author":"Gu","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109601_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109601_b0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jcph.1340","article-title":"Population Pharmacokinetics of Adjunctive Lacosamide in Pediatric Patients With Epilepsy","volume":"59","author":"Winkler","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109601_b0080","doi-asserted-by":"crossref","first-page":"e0049321","DOI":"10.1128\/AAC.00493-21","article-title":"Model-Oriented Dose Optimization of Voriconazole in Critically Ill Children","volume":"65","author":"Wang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.yebeh.2023.109601_b0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4103\/2141-9248.144907","article-title":"Evaluation of five formulae for estimating body surface area of nigerian children","volume":"4","author":"Orimadegun","year":"2014","journal-title":"Ann Med Health Sci Res"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109601_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180565","article-title":"Validation of glomerular filtration rate-estimating equations in Chinese children","volume":"12","author":"Zheng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2023.109601_b0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2147\/DDDT.S154388","article-title":"Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines","volume":"12","author":"Reimers","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109601_b0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/epi.12085","article-title":"Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers","volume":"54","author":"Cawello","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109601_b0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40261-015-0277-7","article-title":"Effect of age and sex on lacosamide pharmacokinetics in healthy adult subjects and adults with focal epilepsy","volume":"35","author":"Schaefer","year":"2015","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109601_b0110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/FTD.0000000000000538","article-title":"Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages","volume":"40","author":"May","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2023.109601_b0115","first-page":"4890287","article-title":"Acute Uric Acid Nephropathy following Epileptic Seizures: Case Report and Review","volume":"2019","author":"Patel","year":"2019","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.yebeh.2023.109601_b0120","article-title":"Plasma lacosamide monitoring in children with epilepsy: Focus on reference therapeutic range and influencing factors","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109601_b0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/jcph.1840","article-title":"Use of Real-World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of Age","volume":"61","author":"Lukka","year":"2021","journal-title":"J Clin Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023005206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023005206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T03:49:20Z","timestamp":1719028160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023005206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":25,"alternative-id":["S1525505023005206"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109601","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109601"}}